Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer
- Conditions
- Sexual Dysfunction, PhysiologicalSexual Dysfunctions, PsychologicalUrinary Bladder NeoplasmsHematuriaErectile Dysfunction
- Registration Number
- NCT02381912
- Lead Sponsor
- Herlev Hospital
- Brief Summary
The purpose of the study is to investigate sexual function in patients suspected of non muscle invasive bladder cancer (NMIBC). The investigators hypothesis is that reduced sexual function is underdiagnosed in patients with non-muscle invasive bladder cancer and that active examination and treatment may worsen the sexual function.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 210
- Patients with primary hematuria, both gross and microscopic
- Men and women older or equal to 40 years of age
- Signed informed consent statement
- Men and women younger than 40 years of age
- Patients with recurrent hematuria and known causative disease
- Already known urogenital cancer
- Previous massive pelvic surgery or pelvic radiotherapy
- TUR-P within the last 2 months
- Participants diagnosed with tumors originating from the ureters, renal pelvis and kidney, and bladder tumors at T stage more than or equal to T1b.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in sexual function 4 months Change in sexual function measured by the "EORTC QLQ-BLS24 sexual functioning questions"
- Secondary Outcome Measures
Name Time Method Change in erectile function 4 months Change in erectile function measured by the Erection Hardness Scale
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Herlev Hospital
🇩🇰Herlev, Denmark
Herlev Hospital🇩🇰Herlev, Denmark